Sufentanil Citrate
橼酸舒芬太尼
Report date: 2026/05/26 20:00:28
NME
Base Information
Drug NameSufentanil Citrate
Drug Alias Name +[23]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1984/05/04
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAkorn Inc
China Registration ClassN/A
Develop Information
Active CompaniesUniversity of Texas Southwestern Medical CenterRising Pharma Holdings IncAlora Pharmaceuticals LLC +[5]
Inactive CompaniesUtah State UniversityDurectFgk Representative Service Gmbh +[7]
Active Indications
Inactive Indications